Birgitta A. R. Schmidt

Birgitta A. R. Schmidt

Auto-generated profile, based on publicly available information

Birgitta A. R. Schmidt

Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DPDipak Panigrahy
Dipak Panigrahy
AGAllison Gartung
Allison Gartung
JYJun Yang
Jun Yang
HYHaixia Yang
Haixia Yang
MGMolly M. Gilligan
Molly M. Gilligan
VSVikas P. Sukhatme
Vikas P. Sukhatme
Cancer therapy is a double-edged sword, as surgery and chemotherapy can induce an inflammatory/immunosuppressive injury response that promotes dormancy escape and tumor recurrence. We hypothesized that these events could be altered by early blockade of the inflammatory cascade and/or by accelerating the resolution of inflammation. Preoperative, but not postoperative, administration of the nonsteroidal antiinflammatory drug ketorolac and/or resolvins, a family of specialized proresolving autacoid mediators, eliminated micrometastases in multiple tumor-resection models, resulting in long-term survival. Ketorolac unleashed anticancer T cell immunity that was augmented by immune checkpoint blockade, negated by adjuvant chemotherapy, and dependent on inhibition of the COX-1/thromboxane A2 (TXA2) pathway. Preoperative stimulation of inflammation resolution via resolvins (RvD2, RvD3, and RvD4) inhibited metastases and induced T cell responses. Ketorolac and resolvins exhibited synergistic antitumor activity and prevented surgery- or chemotherapy-induced dormancy escape. Thus, simultaneously blocking the ensuing proinflammatory response and activating endogenous resolution programs before surgery may eliminate micrometastases and reduce tumor recurrence.

23 July 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
PSPranali N. Shah
Pranali N. Shah
GRGeorge A. Romar
George A. Romar
AMArtür Manukyan
Artür Manukyan
WKWei-Che Ko
Wei-Che Ko
PHPei-Chen Hsieh
Pei-Chen Hsieh
SDSherrie J. Divito
Sherrie J. Divito
Delayed-type drug hypersensitivity reactions are major causes of morbidity and mortality. The origin, phenotype, and function of pathogenic T cells across the spectrum of severity require investigation. We leveraged recent technical advancements to study skin-resident memory T cells (TRMs) versus recruited T cell subsets in the pathogenesis of severe systemic forms of disease, Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS), and skin-limited disease, morbilliform drug eruption (MDE). Microscopy, bulk transcriptional profiling, and single-cell RNA-sequencing (scRNA-Seq) plus cellular indexing of transcriptomes and epitopes by sequencing (CITE-Seq) plus T cell receptor sequencing (TCR-Seq) supported clonal expansion and recruitment of cytotoxic CD8 + T cells from circulation into skin along with expanded and nonexpanded cytotoxic CD8 + skin TRM in SJS/TEN. Comparatively, MDE displayed a cytotoxic T cell profile in skin without appreciable expansion and recruitment of cytotoxic CD8 + T cells from circulation, implicating TRMs as potential protagonists in skin-limited disease. Mechanistic interrogation in patients unable to recruit T cells from circulation into skin and in a parallel mouse model supported that skin TRMs were sufficient to mediate MDE. Concomitantly, SJS/TEN displayed a reduced Treg signature compared with MDE. DRESS demonstrated recruitment of cytotoxic CD8 + T cells into skin as in SJS/TEN, yet a pro-Treg signature as in MDE. These findings have important implications for fundamental skin immunology and clinical care.

1 November 2015 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
HKHasan Khosravi
Hasan Khosravi
BSBirgitta Schmidt
Birgitta Schmidt
JHJennifer T. Huang
Jennifer T. Huang

1 May 2017 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ESEmily A. Simons
Emily A. Simons
JHJennifer T. Huang
Jennifer T. Huang
BSBirgitta Schmidt
Birgitta Schmidt

3 November 2015 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
CCC. Crall
C. Crall
KMK.W. Morley
K.W. Morley
GRGuilherme Rabinowits
Guilherme Rabinowits
BSB. Schmidt
B. Schmidt
ABA. Dioun Broyles
A. Dioun Broyles
JHJ.T. Huang
J.T. Huang

1 September 2012 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JHJennifer T. Huang
Jennifer T. Huang
JMJason Mantagos
Jason Mantagos
RKRoger Kapoor
Roger Kapoor
BSBirgitta Schmidt
Birgitta Schmidt
SMSheilagh Maguiness
Sheilagh Maguiness